Search
Search Results
##search.searchResults.foundPlural##
-
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1806PDF: 901HTML: 946Referring article: 747 -
-
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1212PDF: 971HTML: 200 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2785PDF: 936HTML: 7318 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1580PDF: 576HTML: 218 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1666PDF: 1154HTML: 240 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3510PDF: 2390HTML: 1448 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3287PDF: 1232HTML: 2190 -
EFFECT OF FRESH VERSUS CRYOPRESERVED GRAFTS ON FEBRILE NEUTROPENIA AND INFECTIONS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: FACTORS DETERMINING MORTALITY. Fresh vs Frozen Grafts: Infection and Outcome
765PDF: 498HTML: 76 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1139PDF: 817HTML: 2171Figue 1: 170 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4027PDF: 3326HTML: 193 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1263PDF: 606HTML: 3069 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2146PDF: 1461HTML: 260 -
As a Rare Site of Invasive Fungal Infection, Chronic Granulomatous Aspergillus Synovitis: A Case Report
1690PDF: 619HTML: 1508Figure 1: MRI demonstrating Aspergillus synovitis: 183Figure 2:MRI demonstrating Aspergillus synovitis: 186 -
A MULTICENTER EXPERIENCE FROM LEBANON IN CHILDHOOD AND ADOLESCENT ACUTE MYELOID LEUKEMIA:HIGH RATE OF EARLY DEATH IN CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA.
2052PDF: 1109HTML: 7687cover letter paper final AML: 212 -
-
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2429PDF: 780HTML: 1729 -
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
2002PDF: 791HTML: 1037 -
The EVOLVING ROLE OF HAEMATOLOGY NURSING PRACTICE: A CROSS-SECTIONAL SURVEY
1766Suppl. Files: 859HTML: 414PDF: 730 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1366PDF: 813HTML: 3112 -
DIAMOND BLACKFAN ANEMIA: A TERTIARY CARE CENTRE EXPERIENCE
1786PDF: 849HTML: 3588Diamond Blackfan Anemia: A Tertiary care centre experience: 251 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
4617PDF: 1308HTML: 1902Untitled: 179Untitled: 175 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9002PDF: 6034HTML: 87933Fig.1b: 180Fig.1c: 183Fig.2a: 173Fig.2b: 172Fig.4: 185Fig.2c: 180Fig.3: 179Tab.1: 224Tab.2: 204Tab.3: 186Tab.4: 219Fig1a: 178







